|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Bank-Owned Certificates of Deposit | ||||||||||||||||||||
| Securities Available for Sale, at Fair Value | ||||||||||||||||||||
| Loans, Net of Allowance for Credit Losses of $57,418 at June 30, 2026 (unaudited) and $56,443 at December 31, 2025 | ||||||||||||||||||||
| Federal Home Loan Bank (FHLB) Stock, at Cost | ||||||||||||||||||||
| Premises and Equipment, Net | ||||||||||||||||||||
| Foreclosed Assets | ||||||||||||||||||||
| Accrued Interest | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other Intangible Assets, Net | ||||||||||||||||||||
| Bank-Owned Life Insurance | ||||||||||||||||||||
| Other Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| LIABILITIES | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Noninterest Bearing | ||||||||||||||||||||
| Interest Bearing | ||||||||||||||||||||
| Total Deposits | ||||||||||||||||||||
| Notes Payable | ||||||||||||||||||||
| FHLB Advances | ||||||||||||||||||||
| Subordinated Debentures, Net of Issuance Costs | ||||||||||||||||||||
| Accrued Interest Payable | ||||||||||||||||||||
| Other Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Preferred Stock - Issued and Outstanding 27,600 Series A shares ($2,500 liquidation preference) at June 30, 2026 (unaudited) and December 31, 2025 | ||||||||||||||||||||
| Common Stock - Issued and Outstanding 27,880,830 at June 30, 2026 (unaudited) and 27,759,970 at December 31, 2025 | ||||||||||||||||||||
| Additional Paid-In Capital | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Accumulated Other Comprehensive Gain (Loss) | ||||||||||||||||||||
| Total Shareholders' Equity | ||||||||||||||||||||
| Total Liabilities and Equity | ||||||||||||||||||||
Loading...
